Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 184

$103.5m for Dicerna Pharmaceuticals

US-based biopharmaceutical company Dicerna Pharmaceuticals has closed their initial public offering selling 6.9 million shares of common stock.

Mar 20, 2014

Chukong seeks $150m high score

Chinese mobile game developer Chukong Technologies is preparing a $150m US initial public offering.

Mar 20, 2014

$19m for Biocept in IPO

Molecular oncology diagnostics company Biocept has raised $19m in their initial public offering by selling 1.9 million shares of common stock.

Mar 20, 2014

Alder Biopharmaceuticals seeks to avoid headache as it files for $115m IPO

Alder, which is developing antibodies to fight migraine and arthritis, secured $38m in a 2012 venture round backed by Novo and TPG, and will use the money from the initial public offering to forward testing.

Mar 20, 2014

Johnson & Johnson-funded Aldeyra sets IPO range

The aldehyde disease specialist, in which Johnson & Johnson owns a 44.5% stake, could potentially raise up to $27.6m from the initial public offering.

Mar 19, 2014

Agile Therapeutics limbers up for $69m IPO

Kaiser Permanente-backed Agile plans to use the proceeds from its initial public offering to support clinical trials of its lead product candidate, a weekly contraceptive patch.

Mar 19, 2014

Celladon raises $50.6m in IPO

US-based cardiovascular drug developer Celladon has raised $50.6m in their initial public offering selling 6.325 million shares at $8 each.

Mar 18, 2014

Weibo posts plans for $500m IPO

Weibo has become the latest Chinese company to tap the US public markets, targeting $500 million from its initial public offering, and plans to leverage its partnership with minority shareholder Alibaba to maxmise advertising revenue.

Mar 18, 2014

Castlight raises healthy $204m from IPO

Cleveland Clinic-backed healthcare services analytics provider Castlight Health has closed a $204.24m initial public offering

Mar 17, 2014

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here